Filtered By:
Condition: Cholesterol
Procedure: Coronary Angioplasty
This page shows you your search results in order of date. This is page number 5.
Order by Relevance | Date
Total 178 results found since Jan 2013.
Paradoxical Long-Term Impact Between Serum Apolipoprotein E and High-Density Lipoprotein Cholesterol in Patients Undergoing Percutaneous Coronary Intervention
CONCLUSIONS: Serum ApoE levels may have a paradoxical impact on the future cardiovascular risk depending on the HDL-C status in patients with CAD.PMID:35934781 | DOI:10.5551/jat.63535
Source: Journal of Atherosclerosis and Thrombosis - August 7, 2022 Category: Cardiology Authors: Tatsuya Fukase Tomotaka Dohi Ryota Nishio Mitsuhiro Takeuchi Norihito Takahashi Yuichi Chikata Hirohisa Endo Shinichiro Doi Hiroki Nishiyama Iwao Okai Hiroshi Iwata Shinya Okazaki Katsumi Miyauchi Hiroyuki Daida Tohru Minamino Source Type: research
Effect of the Early Application of Evolocumab on Blood Lipid Profile and Cardiovascular Prognosis in Patients with Extremely High-Risk Acute Coronary Syndrome
This study was a prospective, randomized controlled study. A total of 136 patients with extremely high-risk ACS with LDL-C ≥ 3.0 mmol/L after percutaneous coronary intervention (PCI) treatment were randomly assigned 1:1 to the control group (atorvastatin 40 mg/day and ezetimibe 10 mg/day) or the evolocumab group (evolocumab 140 mg every 2 weeks combined with atorvastatin 40 mg/day and ezetimibe 10 mg/day). We compared the blood lipid profiles, major adverse cardiovascular events (MACEs), and adverse reactions. MACEs included cardiogenic death, nonfatal myocardial infarction, nonfatal stroke, and readmission due to angina...
Source: International Heart Journal - July 13, 2022 Category: Cardiology Authors: Yan Hao Yu-Lin Yang Yong-Chao Wang Jian Li Source Type: research
